Exscientia
VerifiedApplying artificial intelligence and big data processing to accelerate discovery and development of drugs.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$510m (Public information from Jul 2024)
Share price
$5.22 EXAI
Company register number SC428761
Oxford England (HQ), Dundee Scotland (founding location)
Deals in current and previous year:
| GBP | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 10 % | 58 % | (1 %) | (3 %) | 188 % | (15 %) | (29 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (240 %) | (207 %) | (697 %) | (717 %) | (250 %) | (322 %) | (471 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (230 %) | (180 %) | (436 %) | (727 %) | (321 %) | (390 %) | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 113 % | 161 % | 473 % | 640 % | - | - | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | $0.0 | round |
| investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor investor | $0.0 Valuation: $0.0 57.5x EV/LTM Revenues -23.9x EV/LTM EBITDA | round | |
| investor | $0.0 | round | |
| N/A | $0.0 Valuation: $0.0 166.7x EV/LTM Revenues -69.4x EV/LTM EBITDA | round | |
| investor | $0.0 | round | |
* | $2.3m | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about Exscientia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Exscientia
Edit
ACQUISITION by Exscientia Nov 2018
ACQUISITION by Exscientia Jun 2021